(Q43266411)

17 November 2017

title

Cost-effectiveness of replacing NSAIDs with coxibs: diclofenac and celecoxib in rheumatoid arthritis (English)

1 reference

17 November 2017

1 reference

1 reference

2

Tore Kristian Kvien

1 reference

17 November 2017

Ivar Sønbø Kristiansen

series ordinal

1

object named as

Ivar Sønbø Kristiansen

1 reference

17 November 2017

language of work or name

1 reference

1 June 2002

1 reference

Expert Review of Pharmacoeconomics & Outcomes Research

17 November 2017

published in

1 reference

17 November 2017

volume

2

1 reference

17 November 2017

issue

3

1 reference

17 November 2017

page(s)

229-241

1 reference

Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2.

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2.3.229

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2.3.229

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2.3.229

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2.3.229

Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2.3.229

Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2.3.229

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2.3.229

Health status index models for use in resource allocation decisions. A critical review in the light of observed preferences for social choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2.3.229

Individual utilities are inconsistent with rationing choices: A partial explanation of why Oregon's cost-effectiveness list failed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2.3.229

The person-trade-off approach to valuing health care programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2.3.229

NSAIDS and selective COX-2 inhibitors: competition between gastroprotection and cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2.3.229

Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2.3.229

Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2.3.229

21 January 2018

Identifiers

DOI

10.1586/14737167.2.3.229

1 reference

release_jdmtjpgxorgmtijfg5vtcw7kni

17 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jdmtjpgxorgmtijfg5vtcw7kni

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference